Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Journal: British journal of haematology
Published: April 02, 2019
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
Journal: American journal of hematology
Published: June 22, 2017
Population Pharmacokinetics and Exposure Response Assessment of CC-292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic Leukemia.
Journal: Journal of clinical pharmacology
Published: January 24, 2017
Novel therapies for aggressive B-cell lymphoma.
Journal: Advances in hematology
Published: October 12, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026